-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Harpoon Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2023.
- Harpoon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.8M, a 84.5% increase year-over-year.
- Harpoon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$30.5M, a 57% increase year-over-year.
- Harpoon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$67.7M, a 42% increase from 2021.
- Harpoon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$117M, a 134% decline from 2020.
- Harpoon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$49.9M, a 10.2% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)